Glucose-Dependent Anaplerosis in Cancer Cells Is Required for Cellular Redox Balance in the Absence of Glutamine

dc.contributor.author Cetinbas, Naniye Malli
dc.contributor.author Sudderth, Jessica
dc.contributor.author Harris, Robert C.
dc.contributor.author Cebeci, Aysun
dc.contributor.author Negri, Gian L.
dc.contributor.author Yilmaz, Oemer H.
dc.contributor.author Sorensen, Poul H.
dc.date.accessioned 2025-09-25T10:47:50Z
dc.date.available 2025-09-25T10:47:50Z
dc.date.issued 2016
dc.description.abstract Cancer cells have altered metabolism compared to normal cells, including dependence on glutamine (GLN) for survival, known as GLN addiction. However, some cancer cell lines do not require GLN for survival and the basis for this discrepancy is not well understood. GLN is a precursor for antioxidants such as glutathione (GSH) and NADPH, and GLN deprivation is therefore predicted to deplete antioxidants and increase reactive oxygen species (ROS). Using diverse human cancer cell lines we show that this occurs only in cells that rely on GLN for survival. Thus, the preference for GLN as a dominant antioxidant source defines GLN addiction. We show that despite increased glucose uptake, GLN addicted cells do not metabolize glucose via the TCA cycle when GLN is depleted, as revealed by C-13-glucose labeling. In contrast, GLN independent cells can compensate by diverting glucose-derived pyruvate into the TCA cycle. GLN addicted cells exhibit reduced PDH activity, increased PDK1 expression, and PDK inhibition partially rescues GLN starvation-induced ROS and cell death. Finally, we show that combining GLN starvation with pro-oxidants selectively kills GLN addicted cells. These data highlight a major role for GLN in maintaining redox balance in cancer cells that lack glucose-dependent anaplerosis. en_US
dc.description.sponsorship British Columbia Cancer Foundation; Prostate Cancer Canada-Movember Foundation [T2013-1]; NIH [R01 CA157996, R00 AG045144]; Damon-Runyon Cancer Research Foundation; Scientific and Technological Research Council of Turkey [2219]; Canadian Institutes for Health Research en_US
dc.description.sponsorship This research was supported by funds from the British Columbia Cancer Foundation through generous donations from Team Finn and Ride to Conquer Cancer and from Prostate Cancer Canada-Movember Foundation Team grant T2013-1 (to PHS), and from the NIH (R01 CA157996) and Damon-Runyon Cancer Research Foundation (to RJD) and NIH (R00 AG045144, OHY). AC was funded by programme 2219 of The Scientific and Technological Research Council of Turkey. NMC was funded by the Canadian Institutes for Health Research through a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award. en_US
dc.identifier.doi 10.1038/srep32606
dc.identifier.issn 2045-2322
dc.identifier.scopus 2-s2.0-84986592993
dc.identifier.uri https://doi.org/10.1038/srep32606
dc.identifier.uri https://hdl.handle.net/20.500.12573/3901
dc.language.iso en en_US
dc.publisher Nature Portfolio en_US
dc.relation.ispartof Scientific Reports en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.title Glucose-Dependent Anaplerosis in Cancer Cells Is Required for Cellular Redox Balance in the Absence of Glutamine en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 57191888009
gdc.author.scopusid 35198961800
gdc.author.scopusid 57191096479
gdc.author.scopusid 57195269881
gdc.author.scopusid 55588663400
gdc.author.scopusid 57191092828
gdc.author.scopusid 6602324499
gdc.author.wosid Deberardinis, Ralph/Lsl-9694-2024
gdc.author.wosid Cebeci Aydin, Aysun/Hke-1740-2023
gdc.bip.impulseclass C4
gdc.bip.influenceclass C4
gdc.bip.popularityclass C4
gdc.coar.access open access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department Abdullah Gül University en_US
gdc.description.departmenttemp [Cetinbas, Naniye Malli; Negri, Gian L.; Sorensen, Poul H.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1L3, Canada; [Cetinbas, Naniye Malli; Negri, Gian L.; Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Sudderth, Jessica; Harris, Robert C.; DeBerardinis, Ralph J.] Univ Texas Southern Med Ctr, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Cetinbas, Naniye Malli; Cebeci, Aysun; Yilmaz, Oemer H.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Cebeci, Aysun] Abdullah Gul Univ, Fac Engn, TR-38170 Kayseri, Turkey; [Cetinbas, Naniye Malli; Yilmaz, Oemer H.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yilmaz, Oemer H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yilmaz, Oemer H.] Harvard Med Sch, Boston, MA 02114 USA en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.volume 6 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q1
gdc.identifier.openalex W2509261975
gdc.identifier.pmid 27605385
gdc.identifier.wos WOS:000382638700001
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.accesstype GOLD
gdc.oaire.diamondjournal false
gdc.oaire.downloads 1
gdc.oaire.impulse 14.0
gdc.oaire.influence 3.387121E-9
gdc.oaire.isgreen true
gdc.oaire.keywords MECHANISM
gdc.oaire.keywords Cell Survival
gdc.oaire.keywords Glutamine
gdc.oaire.keywords Citric Acid Cycle
gdc.oaire.keywords Apoptosis
gdc.oaire.keywords METABOLISM
gdc.oaire.keywords Article
gdc.oaire.keywords Antioxidants
gdc.oaire.keywords TUMOR-SUPPRESSOR PTEN
gdc.oaire.keywords PYRUVATE-DEHYDROGENASE COMPLEX
gdc.oaire.keywords Cell Line, Tumor
gdc.oaire.keywords Neoplasms
gdc.oaire.keywords 616
gdc.oaire.keywords Pyruvic Acid
gdc.oaire.keywords C-MYC
gdc.oaire.keywords Humans
gdc.oaire.keywords OXIDATIVE STRESS
gdc.oaire.keywords ROS
gdc.oaire.keywords Glutathione
gdc.oaire.keywords Glucose
gdc.oaire.keywords DNA-DAMAGE
gdc.oaire.keywords SURVIVAL
gdc.oaire.keywords GROWTH
gdc.oaire.keywords Reactive Oxygen Species
gdc.oaire.keywords Oxidation-Reduction
gdc.oaire.popularity 1.7755479E-8
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 0301 basic medicine
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 0303 health sciences
gdc.oaire.views 2
gdc.openalex.collaboration International
gdc.openalex.fwci 2.08794535
gdc.openalex.normalizedpercentile 0.87
gdc.opencitations.count 36
gdc.plumx.crossrefcites 25
gdc.plumx.facebookshareslikecount 121
gdc.plumx.mendeley 78
gdc.plumx.pubmedcites 13
gdc.plumx.scopuscites 36
gdc.scopus.citedcount 36
gdc.virtual.author Cebeci Aydın, Aysun
gdc.wos.citedcount 35
relation.isAuthorOfPublication b06cdd89-81fb-4bc6-874b-75d54c748c3b
relation.isAuthorOfPublication.latestForDiscovery b06cdd89-81fb-4bc6-874b-75d54c748c3b
relation.isOrgUnitOfPublication 665d3039-05f8-4a25-9a3c-b9550bffecef
relation.isOrgUnitOfPublication 03adf3b0-3511-421e-b492-8fe188140fc0
relation.isOrgUnitOfPublication ef13a800-4c99-4124-81e0-3e25b33c0c2b
relation.isOrgUnitOfPublication.latestForDiscovery 665d3039-05f8-4a25-9a3c-b9550bffecef

Files